Reclassification of gabapentin and pregabalin as CDs from 1st April 2019 – update

Community pharmacy teams are reminded that from 1st April 2019, pregabalin and gabapentin will be reclassified as Schedule 3 Controlled Drugs (CDs).NHS England has published a guidance document providing information on changes to the law relating to the reclassification of the drugs gabapentin and pregabalin and a patient leaflet informing patients of the changes and how it will affect them.Pharmacy teams are also reminded of the national roll-out of Schedule 2 and 3 CDs in EPS. This means that the number of CD prescriptions that pharmacies receive via EPS will increase significantly as more GP practices have the functionality switched on.

PSNC’s updated briefing provides detailed information for community pharmacy teams with answers to some commonly raised questions.

NHE England Controlled Drugs regulations and resources